Clinical Trial Update: Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients [Phase 2, Phase 3]

View source ↗

Summary

This study evaluates subcutaneous abatacept in Japanese patients with rheumatoid arthritis, examining efficacy, pharmacokinetics, safety, and immunogenicity in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-02-07